Wednesday, July 2, 2025
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO North America > News > Moderna sues Pfizer/BioNTech over Covid vaccine technology

Moderna sues Pfizer/BioNTech over Covid vaccine technology

in News
Moderna sues Pfizer/BioNTech over Covid vaccine technology
Share on LinkedinShare on WhatsApp

Moderna is suing Pfizer and BioNTech for patent infringement in the development of the first U.S. Covid-19 vaccine approved, the company announced Friday.

The Cambridge, Massachusetts firm claims partners Pfizer and BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before Covid-19 emerged late 2019.

“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the Covid-19 pandemic,” Moderna CEO Stephane Bancel said in the statement.

Moderna had been an innovator in the messenger RNA (mRNA) vaccine technology, which shortens approval processes to months, instead of the years it took to be completed.

The lawsuit was filed in U.S. District Court in Massachusetts and the Regional Court of Dusseldorf in Germany.

The U.S. Food and Drug Administration granted emergency use authorization for the vaccine to both Pfizer/BioNTech and Moderna in consecutive weeks in December 2020.

New York based Pfizer and Mainz, Germany based BioNTech are already facing multiple lawsuits from other companies who say the partnership’s vaccine infringes on their patents.

Moderna has also been sued for patent infringement in the U.S. and has an ongoing dispute with the U.S. National Institutes of Health over rights to mRNA technology.

Tags: BioNTechCOVID vaccineFDAModernaPfizer

Related Posts

Hyundai and Kia to adopt Tesla EV chargers
News

Tesla stock rises as company reports steep sales decline

‘Big Beautiful Bill’ Medicaid cuts could leave millions uninsured
News

‘Big Beautiful Bill’ Medicaid cuts could leave millions uninsured

Del Monte Foods files for bankruptsy
News

Del Monte Foods files for bankruptsy

US job availability drops to new two-year low
News

Jobs report shows unexpected increase

“Big Beautiful Bill” all-nighter divides Senate
News

“Big Beautiful Bill” all-nighter divides Senate

Musk-Trump tensions escalate
News

Musk-Trump tensions escalate

Hyatt sells Playa portfolio for $2 billion
News

Hyatt sells Playa portfolio for $2 billion

TikTok’s day in court arrives
News

Trump awaits China’s approval for TikTok buyer group

Buffett: AI scams are the next big ‘growth industry’
News

Philanthropist Warren Buffett donates $6 billion in shares

Senior U.S. officials visit China for high-level economic talks
News

US, China formalize trade deal

No Result
View All Result

Recent Posts

  • Nasdaq’s New Survey Reveals: Next-Gen Investors Embrace Advanced Technology ETFs
  • Blackstone’s Jon Gray on Strategic Discipline, AI, and Entrepreneurial Leadership
  • Tesla stock rises as company reports steep sales decline
  • ‘Big Beautiful Bill’ Medicaid cuts could leave millions uninsured
  • Del Monte Foods files for bankruptsy

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.